377 related articles for article (PubMed ID: 29899003)
1. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
Friedrich R; Rappold E; Bogdan C; Held J
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
[TBL] [Abstract][Full Text] [Related]
2. Beta-d-Glucan for Diagnosing
Mercier T; Guldentops E; Patteet S; Beuselinck K; Lagrou K; Maertens J
J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918045
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
De Carolis E; Marchionni F; Torelli R; Angela MG; Pagano L; Murri R; De Pascale G; De Angelis G; Sanguinetti M; Posteraro B
PLoS One; 2020; 15(7):e0236095. PubMed ID: 32726358
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
[TBL] [Abstract][Full Text] [Related]
5. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
[TBL] [Abstract][Full Text] [Related]
6. Use of β-D-glucan in diagnosis of suspected
Juniper T; Eades CP; Gil E; Fodder H; Quinn K; Morris-Jones S; Gorton RL; Wey EQ; Post FA; Miller RF
Int J STD AIDS; 2021 Oct; 32(11):1074-1077. PubMed ID: 34106017
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of Pneumocystis jirovecii in clinical specimens by different methods].
Tekinşen FF; Koç AN
Mikrobiyol Bul; 2013 Oct; 47(4):658-67. PubMed ID: 24237434
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.
Son HJ; Sung H; Park SY; Kim T; Lee HJ; Kim SM; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
PLoS One; 2017; 12(11):e0188860. PubMed ID: 29190812
[TBL] [Abstract][Full Text] [Related]
9. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
Damiani C; Le Gal S; Da Costa C; Virmaux M; Nevez G; Totet A
J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
[TBL] [Abstract][Full Text] [Related]
10. Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
Prüller F; Wagner J; Raggam RB; Hoenigl M; Kessler HH; Truschnig-Wilders M; Krause R
Med Mycol; 2014 Jul; 52(5):455-61. PubMed ID: 24906361
[TBL] [Abstract][Full Text] [Related]
11. Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction.
Morjaria S; Frame J; Franco-Garcia A; Geyer A; Kamboj M; Babady NE
Clin Infect Dis; 2019 Sep; 69(8):1303-1309. PubMed ID: 30561560
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia.
Lahmer T; da Costa CP; Held J; Rasch S; Ehmer U; Schmid RM; Huber W
Mycopathologia; 2017 Aug; 182(7-8):701-708. PubMed ID: 28378239
[TBL] [Abstract][Full Text] [Related]
13. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.
Hammarström H; Grankvist A; Broman I; Kondori N; Wennerås C; Gisslen M; Friman V
BMC Infect Dis; 2019 Jul; 19(1):658. PubMed ID: 31337356
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Turbidimetric β-d-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia.
Dichtl K; Seybold U; Wagener J
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29720434
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Performance of the Dynamiker Fungus (1-3)-β-D-Glucan and Fungitell Assay for Diagnosis of Candidemia: Need for New Cut-off Development and Test Validation.
Yazdanpanah S; Rahbarmah M; Motamedi M; Khodadadi H
Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116118. PubMed ID: 37992564
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
Alam FF; Mustafa AS; Khan ZU
BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis.
Karageorgopoulos DE; Qu JM; Korbila IP; Zhu YG; Vasileiou VA; Falagas ME
Clin Microbiol Infect; 2013 Jan; 19(1):39-49. PubMed ID: 22329494
[TBL] [Abstract][Full Text] [Related]
19. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains.
Mikulska M; Ullah N; Magnasco L; Codda G; Bartalucci C; Miletich F; Sepulcri C; Willison E; Vena A; Giacobbe DR; di Pilato V; Robba C; Ball L; Marchese A; Bassetti M
Clin Microbiol Infect; 2024 Jun; 30(6):822-827. PubMed ID: 38431255
[TBL] [Abstract][Full Text] [Related]
20. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
White SK; Schmidt RL; Walker BS; Hanson KE
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
